stella
beta
Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia — Stella
Recruiting
Back to Primary Immune Thrombocytopenia (ITP) trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
France
Henri Mondor Hospital, Créteil
View full record on ClinicalTrials.gov